Morningstar Founder Mansueto Sells $6.1M MORN Under 10b5-1

Joseph D. Mansueto, the founder and executive chairman of Morningstar, sold approximately 36,250 shares of MORN across two reporting windows in May 2026, generating roughly $6.12 million in gross proceeds. The May 5-7 tranche moved 21,750 shares for $3.67 million at prices between $166 and $180; a follow-on tranche on May 14-15 sold 14,500 shares for $2.45 million at $165.60 to $171.47. Both filings cite the same pre-arranged Rule 10b5-1 trading plan adopted on November 19, 2025.

The dollar amounts are not what makes this filing worth reading. What matters is the full ownership picture — Mansueto remains the dominant beneficial owner of Morningstar, holding roughly 14.9 million shares (37.5% of the company per his February 2026 13G/A), and the May selling represents less than one-quarter of one percent of his total position. The market periodically misreads founder-side 10b5-1 distributions as conviction-shifting events. On Morningstar, it has never been that.

The 10b5-1 plan, the date, and what it tells you

The November 19, 2025 adoption date matters. Rule 10b5-1 requires a 90-day cooling-off period between plan adoption and the first trade for officers and directors — meaning Mansueto's plan could not have triggered trades before February 17, 2026. The pre-clearance window was timed to follow Morningstar's Q3 2025 earnings disclosure and a board-level confirmation. The trades themselves are mechanical execution against that pre-set schedule.

The cadence supports the mechanical interpretation: small lots ranging from 200 shares to roughly 4,000 shares spread across multiple trading days, with execution at the prevailing bid rather than at staged limit prices. This is the trading-desk signature of a daily VWAP-targeted distribution under a plan, not a discretionary block sale. None of the May filings reference a discretionary trading window opening — the company's own pre-clearance window typically opens for a few business days after earnings, and Morningstar's most recent earnings disclosure was its Q1 2026 release in late April 2026.

The 37.5% stake nobody disputes

The most important data point on the Mansueto filings is Form 4 Table II combined with the standing Schedule 13G. As of his February 12, 2026 Schedule 13G/A, Mansueto reported beneficial ownership of 14,909,759 Morningstar shares — 37.5% of MORN's outstanding common stock. His son Daniel Mansueto separately reported 9.5% beneficial ownership of 3,757,306 shares on the same date. Together, the Mansueto family controls a near-majority of the company.

The May sales of 36,250 shares reduce that combined family stake by less than 20 basis points. Even at the highest historical run-rate of founder selling — 200,000+ shares per quarter in prior years — the position decays at a pace that leaves Mansueto comfortably above the 30% beneficial-ownership threshold for the foreseeable future. He is not exiting. He is distributing.

Cross-check: institutional file

Beyond the Mansueto family stake, Morningstar's institutional file is notable for what it does not contain: there is no active 13D activist filing on the company, and the post-family-trust institutional ownership shows Vanguard Capital Management and the index complex dominating the next tier. BlackRock participates at the standard small-cap index weight. None of those passive holders will move on a founder's 10b5-1 trade.

The only active-conviction holder watch-item on Morningstar is the cluster of small-cap value funds that have used the past three quarters of multiple compression — the stock is down roughly 15% from its February 2026 highs — to build positions. Those buyers, not the founder-side seller, are the read worth surfacing for any reader trying to decide if the May Form 4s change the investment case. They do not.

Forward anchors

Three calendar items frame the next 60-90 days:

• Morningstar's Q2 2026 earnings release is expected in late July 2026. 10b5-1 plan trades typically continue executing through earnings windows unless the plan terms explicitly suspend.
• The November 19, 2025 plan has an unstated end-date that will eventually appear in a future Form 4 footnote when the plan terminates or is amended. A new plan adoption — typically 4-8 weeks after a major earnings cycle — would surface as a fresh footnote in the Mansueto Form 4 stream.
• The next Schedule 13G/A is due no later than February 14, 2027. Watch for any meaningful change to the 37.5% beneficial-ownership figure — that, not the monthly 10b5-1 trickle, would constitute a real ownership-shift signal.

Track the full Form 4 history on Joe Mansueto's insider profile. The pattern over 11,000+ recorded transactions is consistent — long-cadence distributions against a long-tenured family ownership base.

FAQ

How much MORN did Joe Mansueto sell in May 2026?

Across two Form 4 filings covering May 5-7 and May 14-15, 2026, Morningstar founder Joe Mansueto sold approximately 36,250 shares for roughly $6.12 million in gross proceeds. The May 5-7 tranche generated $3.67 million at $166-$180 per share; the May 14-15 tranche generated $2.45 million at $165.60-$171.47.

Did Joe Mansueto sell MORN under a 10b5-1 plan?

Yes. Both May 2026 Form 4 filings cite a pre-arranged Rule 10b5-1 trading plan adopted on November 19, 2025. The 90-day SEC-mandated cooling-off period means the first plan trades could not execute before February 17, 2026. The cadence and lot sizes are consistent with daily VWAP-targeted execution under a pre-set schedule.

How much of Morningstar does Joe Mansueto still own?

As of his February 12, 2026 Schedule 13G/A filing, Mansueto reported beneficial ownership of 14,909,759 Morningstar shares — 37.5% of the company. His son Daniel separately holds 9.5% (3,757,306 shares). The May 2026 sales reduce the combined Mansueto family stake by less than 20 basis points.